Boston Financial & Equity started off 2020 by closing a lease transaction for a Seattle-based drug discovery company. The company founded in 2011, originally funded by family and friends, has raised over $29 million to date. Its approach to drug discovery accelerates the timeline and increases manufacturing efficiencies, reducing the costs to the biopharmaceutical industry.
The company, although it has less than a year of cash, and minimal revenues, has agreements with three of the largest pharma companies. Boston Financial & Equity leased them a $725,000 fermentation system.